These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 15688409)
1. Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma. Du S; Lawrence EJ; Strzelecki D; Rajput P; Xia SJ; Gottesman DM; Barr FG Int J Cancer; 2005 May; 115(1):85-92. PubMed ID: 15688409 [TBL] [Abstract][Full Text] [Related]
2. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue. Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718 [TBL] [Abstract][Full Text] [Related]
3. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929 [TBL] [Abstract][Full Text] [Related]
4. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Barr FG Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823 [TBL] [Abstract][Full Text] [Related]
5. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma. Bennicelli JL; Advani S; Schäfer BW; Barr FG Oncogene; 1999 Jul; 18(30):4348-56. PubMed ID: 10439042 [TBL] [Abstract][Full Text] [Related]
7. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Tiffin N; Williams RD; Shipley J; Pritchard-Jones K Br J Cancer; 2003 Jul; 89(2):327-32. PubMed ID: 12865925 [TBL] [Abstract][Full Text] [Related]
8. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. Kelly KM; Womer RB; Sorensen PH; Xiong QB; Barr FG J Clin Oncol; 1997 May; 15(5):1831-6. PubMed ID: 9164192 [TBL] [Abstract][Full Text] [Related]
9. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions. Collins MH; Zhao H; Womer RB; Barr FG Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344 [TBL] [Abstract][Full Text] [Related]
10. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Bennicelli JL; Edwards RH; Barr FG Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596 [TBL] [Abstract][Full Text] [Related]
11. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K; Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833 [TBL] [Abstract][Full Text] [Related]
12. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Davis RJ; Barr FG Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312 [TBL] [Abstract][Full Text] [Related]
13. [Detection of PAX3/PAX7-FKHR fusion transcript in rhabdomyosarcoma by one-step RT-PCR]. Chang B; Yin BM; Li F; Li XX; Lu TC; Hu WH; Jiang JF; Shi DR Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1336-8. PubMed ID: 12930690 [TBL] [Abstract][Full Text] [Related]
14. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma. Barr FG Cancer Res; 1999 Apr; 59(7 Suppl):1711s-1715s. PubMed ID: 10197585 [TBL] [Abstract][Full Text] [Related]
15. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119 [TBL] [Abstract][Full Text] [Related]
16. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro. Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908 [TBL] [Abstract][Full Text] [Related]
17. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Barr FG; Nauta LE; Davis RJ; Schäfer BW; Nycum LM; Biegel JA Hum Mol Genet; 1996 Jan; 5(1):15-21. PubMed ID: 8789435 [TBL] [Abstract][Full Text] [Related]
18. Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression. Tomescu O; Xia SJ; Strezlecki D; Bennicelli JL; Ginsberg J; Pawel B; Barr FG Lab Invest; 2004 Aug; 84(8):1060-70. PubMed ID: 15184910 [TBL] [Abstract][Full Text] [Related]
19. [Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma]. Gao H; Ou YL; Zhang KR; Zhang ZB; Wang WL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):42-7. PubMed ID: 17285543 [TBL] [Abstract][Full Text] [Related]
20. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Anderson J; Ramsay A; Gould S; Pritchard-Jones K Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]